NCT02675660View on ClinicalTrials.gov

Single and Multiple Doses of an Oral Formulation of L-Homoarginine in Healthy Human Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

April 30, 2014

Primary Completion Date

April 30, 2015

Study Completion Date

January 31, 2016

Conditions
Healthy
Interventions
DIETARY_SUPPLEMENT

L-Homoarginine

125 mg L-homoarginine once daily

DRUG

Placebo

placebo capsules once daily

All Listed Sponsors
lead

Universitätsklinikum Hamburg-Eppendorf

OTHER

NCT02675660 - Single and Multiple Doses of an Oral Formulation of L-Homoarginine in Healthy Human Subjects | Biotech Hunter | Biotech Hunter